Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
24.03.2026
Zum heutigen Welt-Tuberkulose-Tag erscheint eine neue Folge des Podcasts „Mikroben im Visier“ des Forschungsverbunds Leibniz INFECTIONS. Darin gibt Prof. Christoph Lange detaillierte Einblicke in die aktuelle Forschung und die Herausforderungen der globalen Tuberkulose-Bekämpfung und erklärt, warum die tödlichste Infektionskrankheit der Welt trotz moderner Medizin nicht weicht.
23.03.2026
Multidrug-resistant tuberculosis (MDR-TB) is classified by the World Health Organization (WHO) as a high-priority pathogen in the context of antimicrobial resistance (AMR). The WHO European Region is particularly affected, and the Republic of Moldova has one of the highest proportions of drug-resistant TB cases in the region.Against this backdrop, the Research Center Borstel – Leibniz Lung Center, together with the Chir
19.03.2026
At the beginning of the month, a weekly international multidisciplinary TB and NTM consilium was launched by staff from the Research Center Borstel together with partner institutions in Ukraine. The case discussions will take place weekly via videoconference over the next two years and enable continuous professional exchange between the participating institutions